CLINICAL_TRIALS
withdrawal
· 2020-02-17
Clinical Trial Update: Use of Gadolinium in CT Pulmonary Angiography [Phase 4]
Summary
A Phase 4 clinical trial investigating gadolinium use in CT pulmonary angiography has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Pulmonary Embolism | Phase 4 | Status: WITHDRAWN